Ongoing Disclosure Notices – Multiple
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited
Date this disclosure made:
28/02/2019
Date of last disclosure:
2/03/2018
Director or senior manager giving disclosure
Full name(s):David Lovat Gordon HEARN
Name of listed issuer:The a2 Milk Company Limited
Name of related body corporate (if applicable):
Position held in listed issuer:Chair and Non-Executive Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares
Nature of the affected relevant interest(s):
(1) Beneficial owner of unlisted options to
subscribe for Ordinary Shares in the
Company (Options); (2) Legal and beneficial
owner of Ordinary Shares
For that relevant interest-
Number held in class before acquisition or disposal:
(1) 3,300,000 Options; (2) 100,000 Ordinary
Shares
Number held in class after acquisition or disposal:
(1) 3,200,000 Options; (2) 100,000 Ordinary
Shares
Current registered holder(s):
(1) Lovat Partners Limited (2) David Lovat
Gordon Hearn
Registered holder(s) once transfers are registered:
Unknown
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
2
Details of transactions requiring disclosure-
Date of transaction:
(1) and (2) 25/02/19
Nature of transaction:
(1) Issue of 100,000 Ordinary Shares
following exercise of 100,000 options held by
Lovat Partners Limited. Following this,
subsequent transfer of 100,000 Ordinary
Shares from Lovat Partners Limited to David
Hearn. (2) Sale by David Hearn of 100,000
Ordinary Shares on market through broker
facilities (representing less than 3% of David
Hearn's total equity interests in The a2 Milk
Company prior to such disposal) to fund tax
obligations.
Name of any other party or parties to the transaction (if known):
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value, describe the consideration:
(1) $63,000 paid to exercise the Options; (2)
$1,454,657.50 receivable for the on market
sale of Ordinary Shares through broker
facilities
Number of financial products to which the transaction related:
(1) 100,000 Options; (2) 100,000 Ordinary
Shares (arising from the exercise of the
100,000 Options)
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:
27/02/2019
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
Notes
Use this form to disclose all the acquisitions and disposals by a director or senior
manager of a listed issuer, or of a related body corporate, or in specified derivatives. The
disclosure must be made within—
(a) 20 working days after the first acquisition or disposal disclosed in this
notice if the acquisitions or disposals are of a kind referred to in section 297(2)(a) of the
Financial Markets Conduct Act 2013; or
(b) in any other case, 5 trading days after the first acquisition or disposal
disclosed in this notice.
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited
("ATM")
Date this disclosure made:28/02/2019
Date of last disclosure: 3/10/2018
Director or senior manager giving disclosure
Full name(s):Peter Bruce Hinton
Name of listed issuer:
The a2 Milk Company Limited
("ATM")
Name of related body corporate (if applicable):N/A
Position held in listed issuer:Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Ordinary Shares
Nature of the affected relevant interest(s):Legal and beneficial owner
For that relevant interest-
Number held in class before acquisition or disposal:625,000 Ordinary Shares
Number held in class after acquisition or disposal:300,000 Ordinary Shares
Current registered holder(s):Peter Bruce Hinton
Registered holder(s) once transfers are registered:Anne Elizabeth Hinton
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
21/02/2019
Nature of transaction:
Off market transfer of 325,000
ordinary shares to spouse, Anne
Elizabeth Hinton.
Name of any other party or parties to the transaction (if known):
Anne Elizabeth Hinton
The consideration, expressed in New Zealand dollars, paid or recieved for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$4.55 million receivable on the off
market sale of 325,000 ordinary
shares to spouse, Anne Elizabeth
Hinton
Number of financial products to which the transaction related:
325,000 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were aquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the aquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Cerification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclsoure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:27/02/2019
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited
Date this disclosure made:
28/02/2019
Date of last disclosure:
29/08/2018
Director or senior manager giving disclosure
Full name(s):
Peter Jerrold NATHAN
Name of listed issuer:
The a2 Milk Company Limited (Company)
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:Chief Executive Asia Pacific
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Ordinary Shares
Nature of the affected relevant interest(s):
Legal and beneficial owner of Ordinary
Shares
For that relevant interest-
Number held in class before acquisition or disposal:
800,000 Ordinary Shares (together
with 10,000 separate Ordinary Shares,
320,000 Performance Rights and 1,600,000
Options referred to on the following page).
Number held in class after acquisition or disposal:
200,000 Ordinary Shares
(together with 10,000 separate Ordinary
Shares, 320,000 Performance Rights and
1,600,000 Options referred to on the
following page).
Current registered holder(s):Peter Jerrold Nathan
Registered holder(s) once transfers are registered:Unknown
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 23
Details of transactions requiring disclosure-
Date of transaction:
(1) - (23) 21/02/2019
Nature of transaction:
(1) - (23) On market sale of 600,000
Ordinary Shares using broker facilities
Name of any other party or parties to the transaction (if known):(1) - (23) Unknown
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily be converted into a
cash value, describe the consideration:
(1) - (23) $8,850,403.52 received for the on
market sale of 600,000 Ordinary Shares
using broker facilities
Number of financial products to which the transaction related:
(1) - (23) 600,000 Ordinary Shares (in
aggregate)
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Ordinary Shares
Nature of relevant interest:
Beneficial owner
For that relevant interest,-
Number held in class:10,000 Ordinary Shares
Current registered holder(s):Spectre Investments Vic Pty Ltd
Class of quoted financial products:
Unlisted performance rights representing an
entitlement to acquire Ordinary Shares in the
Company
Nature of relevant interest:
Legal and beneficial owner
For that relevant interest,-
Number held in class:320,000 Performance Rights
Current registered holder(s):Peter Jerrold Nathan
Class of quoted financial products:
Unlisted options to subscribe for Ordinary
Shares in the Company
Nature of relevant interest:Legal and beneficial owner
For that relevant interest,-
Number held in class:1,600,000 Options
Current registered holder(s):
Peter Jerrold Nathan
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:
27/02/2019
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
Notes
Use this form to disclose all the acquisitions and disposals by a director or senior
manager of a listed issuer, or of a related body corporate, or in specified derivatives. The
disclosure must be made within—
(a) 20 working days after the first acquisition or disposal disclosed in this
notice if the acquisitions or disposals are of a kind referred to in section 297(2)(a) of the
Financial Markets Conduct Act 2013; or
(b) in any other case, 5 trading days after the first acquisition or disposal
disclosed in this notice.
---
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity
The a2 Milk Company Limited (the Company)
ABN
97 769 415 292
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
David Hearn
Date of last notice
2 March 2018
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Direct and indirect.
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
n/a
Date of change
25 February 2019
No. of securities held prior to change
1. 100,000 fully paid ordinary shares
2. 3,300,000 options to subscribe for
ordinary shares
Class
Fully paid ordinary shares and options to
subscribe for fully paid ordinary shares
Number acquired
100,000 fully paid ordinary shares
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Number disposed
1. 100,000 fully paid ordinary shares
(representing less than 3% of David
Hearn’s total equity interests in The a2
Milk Company prior to such disposal) -
to fund tax obligations.
2. 100,000 options to subscribe for fully
paid ordinary shares (by virtue of
exercise of those options, which
resulted in the issue of the 100,000 fully
paid shares referred to in 1 immediately
above).
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
1. NZ$1,454,657.50 for disposal of fully
paid ordinary shares.
2. NZ$63,000.00 exercise price of options
to subscribe for fully paid ordinary
shares.
No. of securities held after change
1. 100,000 fully paid ordinary shares.
2. 3,200,000 options to subscribe for fully
paid ordinary shares.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-
back
1. On market sale of fully paid ordinary
shares through broker facilities to fund
tax obligations.
2. Exercise of options to subscribe for fully
paid ordinary shares.
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
(if issued securities)
N/A
Date of change
N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
N/A
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
N/A
Interest after change
N/A
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Part 3 –
+
Closed period
Were the interests in the securities or contracts detailed above
traded during a
+
closed period where prior written clearance
was required?
No.
If so, was prior written clearance provided to allow the trade to
proceed during this period?
N/A
If prior written clearance was provided, on what date was this
provided?
N/A
---
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity
The a2 Milk Company Limited (the Company)
ABN
97 769 415 292
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Peter Bruce Hinton
Date of last notice
3 October 2018
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
n/a
Date of change
21 February 2019
No. of securities held prior to change
625,000 fully paid ordinary shares
Class
Fully paid ordinary shares
Number acquired
n/a
Number disposed
325,000 fully paid ordinary shares
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
NZ$4,550,000.00
No. of securities held after change
300,000 fully paid ordinary shares
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-
back
Off-market trade to the director's spouse,
Anne Hinton.
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
(if issued securities)
N/A
Date of change
N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
N/A
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
N/A
Interest after change
N/A
Part 3 –
+
Closed period
Were the interests in the securities or contracts detailed above
traded during a
+
closed period where prior written clearance
was required?
No.
If so, was prior written clearance provided to allow the trade to
proceed during this period?
N/A
If prior written clearance was provided, on what date was this
provided?
N/A
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AOF — AoFrio Limited: Director’s disclosure of interests2019-04-05
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Wellington Drive Technologies Ltd Date this disclosure made: 05-Apr-2019 Date of l…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: D&O Ongoing Disclosures – Multiple2019-01-08
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Fisher & Paykel Healthcare Corporation Limited Date this disclosure made: 8-Jan-19…”
- MEL — Meridian Energy Limited: Ongoing Disclosure Notice2019-02-26
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Meridian Energy Limited Date this disclosure made: 26-Feb-19 Date of last disclosu…”